These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
320 related items for PubMed ID: 25963331
1. Common genetic variation and schizophrenia polygenic risk influence neurocognitive performance in young adulthood. Hatzimanolis A, Bhatnagar P, Moes A, Wang R, Roussos P, Bitsios P, Stefanis CN, Pulver AE, Arking DE, Smyrnis N, Stefanis NC, Avramopoulos D. Am J Med Genet B Neuropsychiatr Genet; 2015 Jul; 168B(5):392-401. PubMed ID: 25963331 [Abstract] [Full Text] [Related]
2. Variability in working memory performance explained by epistasis vs polygenic scores in the ZNF804A pathway. Nicodemus KK, Hargreaves A, Morris D, Anney R, Schizophrenia Psychiatric Genome-wide Association Study (GWAS) Consortium, Wellcome Trust Case Control Consortium 2, Gill M, Corvin A, Donohoe G. JAMA Psychiatry; 2014 Jul 01; 71(7):778-785. PubMed ID: 24828433 [Abstract] [Full Text] [Related]
3. The one and the many: effects of the cell adhesion molecule pathway on neuropsychological function in psychosis. Hargreaves A, Anney R, O'Dushlaine C, Nicodemus KK, Schizophrenia Psychiatric Genome-Wide Association Study Consortium (PGC-SCZ), Wellcome Trust Case Control Consortium 2, Gill M, Corvin A, Morris D, Donohoe G. Psychol Med; 2014 Jul 01; 44(10):2177-87. PubMed ID: 24284030 [Abstract] [Full Text] [Related]
4. Genome-wide association study of cognitive performance in U.S. veterans with schizophrenia or bipolar disorder. Harvey PD, Sun N, Bigdeli TB, Fanous AH, Aslan M, Malhotra AK, Lu Q, Hu Y, Li B, Chen Q, Mane S, Miller P, Rajeevan N, Sayward F, Cheung KH, Li Y, Greenwood TA, Gur RE, Braff DL, Consortium on the Genetics of Schizophrenia (COGS), Brophy M, Pyarajan S, O'Leary TJ, Gleason T, Przygodszki R, Muralidhar S, Gaziano JM, Concato J, Zhao H, Siever LJ. Am J Med Genet B Neuropsychiatr Genet; 2020 Apr 01; 183(3):181-194. PubMed ID: 31872970 [Abstract] [Full Text] [Related]
5. Molecular genetic evidence for overlap between general cognitive ability and risk for schizophrenia: a report from the Cognitive Genomics consorTium (COGENT). Lencz T, Knowles E, Davies G, Guha S, Liewald DC, Starr JM, Djurovic S, Melle I, Sundet K, Christoforou A, Reinvang I, Mukherjee S, DeRosse P, Lundervold A, Steen VM, John M, Espeseth T, Räikkönen K, Widen E, Palotie A, Eriksson JG, Giegling I, Konte B, Ikeda M, Roussos P, Giakoumaki S, Burdick KE, Payton A, Ollier W, Horan M, Donohoe G, Morris D, Corvin A, Gill M, Pendleton N, Iwata N, Darvasi A, Bitsios P, Rujescu D, Lahti J, Hellard SL, Keller MC, Andreassen OA, Deary IJ, Glahn DC, Malhotra AK. Mol Psychiatry; 2014 Feb 01; 19(2):168-74. PubMed ID: 24342994 [Abstract] [Full Text] [Related]
9. Substantial SNP-based heritability estimates for working memory performance. Vogler C, Gschwind L, Coynel D, Freytag V, Milnik A, Egli T, Heck A, de Quervain DJ, Papassotiropoulos A. Transl Psychiatry; 2014 Sep 09; 4(9):e438. PubMed ID: 25203169 [Abstract] [Full Text] [Related]
10. Cognitive analysis of schizophrenia risk genes that function as epigenetic regulators of gene expression. Whitton L, Cosgrove D, Clarkson C, Harold D, Kendall K, Richards A, Mantripragada K, Owen MJ, O'Donovan MC, Walters J, Hartmann A, Konte B, Rujescu D, WTCCC2, Gill M, Corvin A, Rea S, Donohoe G, Morris DW. Am J Med Genet B Neuropsychiatr Genet; 2016 Dec 09; 171(8):1170-1179. PubMed ID: 27762073 [Abstract] [Full Text] [Related]
11. Genome-wide pharmacogenomic study of neurocognition as an indicator of antipsychotic treatment response in schizophrenia. McClay JL, Adkins DE, Aberg K, Bukszár J, Khachane AN, Keefe RS, Perkins DO, McEvoy JP, Stroup TS, Vann RE, Beardsley PM, Lieberman JA, Sullivan PF, van den Oord EJ. Neuropsychopharmacology; 2011 Feb 09; 36(3):616-26. PubMed ID: 21107309 [Abstract] [Full Text] [Related]
13. Stress-Dependent Association Between Polygenic Risk for Schizophrenia and Schizotypal Traits in Young Army Recruits. Hatzimanolis A, Avramopoulos D, Arking DE, Moes A, Bhatnagar P, Lencz T, Malhotra AK, Giakoumaki SG, Roussos P, Smyrnis N, Bitsios P, Stefanis NC. Schizophr Bull; 2018 Feb 15; 44(2):338-347. PubMed ID: 29036523 [Abstract] [Full Text] [Related]
17. Genome-wide study identifies PTPRO and WDR72 and FOXQ1-SUMO1P1 interaction associated with neurocognitive function. LeBlanc M, Kulle B, Sundet K, Agartz I, Melle I, Djurovic S, Frigessi A, Andreassen OA. J Psychiatr Res; 2012 Feb 15; 46(2):271-8. PubMed ID: 22126837 [Abstract] [Full Text] [Related]
18. Influence of NOS1 on verbal intelligence and working memory in both patients with schizophrenia and healthy control subjects. Donohoe G, Walters J, Morris DW, Quinn EM, Judge R, Norton N, Giegling I, Hartmann AM, Möller HJ, Muglia P, Williams H, Moskvina V, Peel R, O'Donoghue T, Owen MJ, O'Donovan MC, Gill M, Rujescu D, Corvin A. Arch Gen Psychiatry; 2009 Oct 15; 66(10):1045-54. PubMed ID: 19805695 [Abstract] [Full Text] [Related]